Methylglyoxal is a well-described GDP in PD fluids and diabetes mellitus [12,55,56], and may impair the TXN/TXNRD1 and glutathione reductase (GSR) system in several cell types including aortic endothelial cells [57,58,59]. The gene discussed is TXNRD1; the disease is diabetes mellitus.